SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-090904
Filing Date
2024-08-19
Accepted
2024-08-19 17:14:33
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2421765d1_s3.htm S-3 195303
2 EXHIBIT 5.1 tm2421765d1_ex5-1.htm EX-5.1 11483
3 EXHIBIT 23.1 tm2421765d1_ex23-1.htm EX-23.1 2410
4 EX-FILING FEES tm2421765d1_ex-filingfees.htm EX-FILING FEES 11403
5 GRAPHIC tm2421765d1_s3sp1img001.jpg GRAPHIC 43644
6 GRAPHIC tm2421765d1_ex5-1img001.jpg GRAPHIC 10055
  Complete submission text file 0001104659-24-090904.txt   295909
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281650 | Film No.: 241221593
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)